Announced the launch of India’s first oral suspension of Favipiravir – Favenza Oral Suspension, used to treat mild to moderate cases of COVID-19.
Feedback
FDC 
Reputation: 17,980 • Jul 13, 2021 4:58 AM
Vote
Comment
Share
NSE:FDC price when posted: 375.85